India JE (Japanese Encephalitis) Vaccine Market Size and Share Analysis Report: Forecast Trends and Outlook (2026-2035)

India JE (Japanese Encephalitis) Vaccine Market Overview

Japanese Encephalitis (JE) vaccine is an inactivated or live-attenuated vaccine that protects against the Japanese Encephalitis virus, a mosquito-borne flavivirus causing inflammation of the brain, primarily in rural and agricultural areas of Asia. The vaccine is crucial for preventing severe neurological complications and fatalities. The JE vaccine market in India is driven by rising immunization initiatives, government support, and growing awareness in endemic regions. Increasing rural healthcare access and periodic outbreaks further boost demand. Continuous public health efforts and strategic collaborations are expected to support sustained market growth in the coming years.

India JE (Japanese Encephalitis) Vaccine Market Growth Drivers

A key factor propelling market growth is the widespread prevalence and high fatality rate of Japanese Encephalitis in India. The virus remains endemic in several regions, with repeated outbreaks leading to severe complications and fatalities. According to Yuvraj Lahre et al. (2024), JE carries a mortality rate of  20–30%, with many survivors left with lasting neurological damage. This critical health threat underscores the urgent need for widespread vaccination, boosting the demand for JE vaccines as preventive healthcare measures are prioritized.

Another major growth driver is the robust involvement of public health authorities in mass immunization campaigns. For instance, in March 2025, the Pune Municipal Corporation launched a comprehensive JE vaccination  campaign targeting children aged 1–15 years across schools. Implemented in phases and supported by mobile health teams, this initiative aims for 95% coverage and integrates awareness programs to improve community engagement. Such strategic public vaccination drives significantly strengthen vaccine accessibility and uptake, positioning the Indian JE vaccine market for sustained expansion in the coming years.

India JE (Japanese Encephalitis) Vaccine Market Trends

One of the leading market trends is the strategic rollout of comprehensive vaccination programs by government authorities.

Surge in Government Vaccination Drives to Boost Market Growth

A key trend shaping the market is the robust public health drive led by the Uttar Pradesh government to eliminate JE from endemic regions. Beginning in May 2017, the Indian government launched an aggressive campaign targeting the immunization of 8.8 million children across 38 districts. By September 2024, the government had administered nearly two crore JE-1 and JE-2 doses and trained over 1.7 lakh ASHA workers under the Dastak Abhiyan to educate households and ensure vaccination compliance. These structured and large-scale efforts have driven a dramatic decline in mortality, from 13.87% in 2017 to 1.23% in 2023, underscoring a significant boost to vaccine uptake and paving the way for continued market growth.

India JE (Japanese Encephalitis) Vaccine Market Share

Pediatric Vaccination Segment to Account for a Significant Market Share Based on Age Group

The market is segmented by age group into pediatric and adult categories. Among these, the pediatric segment is projected to lead the market, driven by an urgent need to protect children, who are the most vulnerable to this life-threatening brain infection. Government-led initiatives, such as the mega vaccination drive launched in February 2024 across Indore, Bhopal, aimed to immunize over 2.5 million children aged 1-15 years. With 22 districts declared JE-endemic and plans underway to include the vaccine in the Universal Immunization Programme, the pediatric population has become the focal point of national health efforts—cementing this segment’s dominance in the market.

India JE (Japanese Encephalitis) Vaccine Market Analysis by Region

Regionally, the market in India is categorized into Northern and Central, Eastern, Western, and Southern regions. Among these, the Northern and Central region is anticipated to dominate the market, owing to a higher disease burden, frequent outbreaks, robust immunization programs, and strong government support. This region also benefits from improved healthcare infrastructure and greater public health awareness.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Leading Players in the India JE (Japanese Encephalitis) Vaccine Market

Other key players in the market include Chengdu Institute of Biological Products and SK Bioscience.

India JE (Japanese Encephalitis) Vaccine Market Segmentation

Key Questions Answered in the India JE (Japanese Encephalitis) Vaccine Market Report

• What was the India JE (Japanese Encephalitis) vaccine market value in 2025?
• What is the India JE (Japanese Encephalitis) vaccine market forecast outlook for 2026-2035?
• What are the major factors aiding the India JE (Japanese Encephalitis) vaccine market demand?
• How has the market performed so far, and how is it anticipated to perform in the coming years?
• What are the market's major drivers, opportunities, and restraints?
• What are the major India JE (Japanese Encephalitis) vaccine market trends?
• Which type is expected to dominate the market segment?
• Which dose type is projected to lead the market segment?
• Which age group is anticipated to drive the market segment?
• Which distribution channel is likely to dominate the market segment?
• Who are the key players involved in the India JE (Japanese Encephalitis) vaccine market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?

Key Benefits for Stakeholders

• Expert Market Research's report provides a detailed quantitative analysis of various market segments, historical and current trends, forecasts, and dynamics within the India JE (Japanese Encephalitis) vaccine market from 2018 to 2034.
• The report offers up-to-date information on key market drivers, challenges, and opportunities in the global healthcare interoperability solutions sector.
• The report uses Porter's five forces analysis to assess the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitutes, helping stakeholders evaluate the level of competition and market attractiveness.
• The competitive landscape section allows stakeholders to understand the competitive environment and provides insights into the current positions of key players in the market.